Assessing Enovix (ENVX) Valuation After Recent Share Price Momentum And Undervaluation Debate

Recent stock move puts Enovix in focus

Recent gains in Enovix (ENVX) over the past month and past 3 months, alongside its latest trading price of $7.98, have brought fresh attention to this lithium ion battery developer.

See our latest analysis for Enovix.

The recent 1 month share price return of 24.69% and 3 month share price return of 51.42% contrast with a 3 year total shareholder return that is down 44.08%. This indicates that momentum has been improving over a weaker long term record.

If sharp moves in Enovix have your attention, this could be a good moment to scan other battery and energy hardware plays through a focused power grid and infrastructure stock screener such as 33 power grid technology and infrastructure stocks

With Enovix shares up strongly in the short term, trading at $7.98 with a market value around $1.63b and analysts seeing room to $13.10, is this pricing still conservative or already reflecting future growth?

Most Popular Narrative: 45.2% Undervalued

With Enovix last closing at $7.98 against a narrative fair value of $14.55, the most followed storyline around this stock leans heavily toward undervaluation and hinges on a sharp inflection in future earnings power.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $432.3 million, earnings will come to $50.1 million, and it would be trading on a PE ratio of 103.0x, assuming you use a discount rate of 11.0%.

Read the complete narrative.

Want to see what sits underneath that bold earnings jump and triple digit future multiple assumptions? The narrative leans on rapid revenue expansion, margin repair and a rich earnings valuation that many investors usually associate with fast growing tech platforms, not hardware heavy manufacturers.

Result: Fair Value of $14.55 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this upbeat story could quickly change if smartphone qualification slips again, or if high capital spending on new manufacturing lines weighs more heavily on cash.

Find out about the key risks to this Enovix narrative.

Another angle on valuation

The narrative fair value of $14.55 suggests Enovix could be undervalued, but the current P/S ratio of 49.5x tells a different story. That is far richer than the US Electrical industry at 2.8x, the peer average at 16.3x, and even the 6.4x fair ratio the market could move toward. Is the stock priced for a flawless execution story?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and concern feels familiar, treat it as a prompt to move quickly. Review the numbers yourself and weigh both sides of the story, starting with 1 key reward and 1 important warning sign.

Looking for more investment ideas?

If Enovix has sharpened your focus, do not stop there. Use targeted stock lists to uncover other opportunities that could fit your approach before others spot them.

• Expand your watchlist with 45 high quality undervalued stocks that combine quality with pricing that may not fully reflect their fundamentals yet.
• Prioritise resilience by checking 64 resilient stocks with low risk scores built around companies with lower risk scores and steadier profiles.
• Zero in on financial strength through the solid balance sheet and fundamentals stocks screener (46 results) and focus on businesses with sturdier balance sheets and underlying fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com